View in EDS HTML Full Text PDF Full Text

3CLpro of SARS-CoV-2 as a new target for bufadienolides: in silico and in vitro study.

Saved in:
Bibliographic Details
Title: 3CLpro of SARS-CoV-2 as a new target for bufadienolides: in silico and in vitro study.
Authors: Kayumov, Muzaffar1, mqayumov0808@gmail.com, Razzokov, Jamoliddin2,3,4, Makhkamov, Mukhriddin5, Radjabov, Murodjon6, Mukhamedov, Nurkhodja1,6, Khakimov, Makhmudjon1, Asrorov, Akmal M.1,7, Khasanov, Okhunjon8, Yashinov, Ansor1,9, Tashmukhamedov, Mugrajitdin1,10, Wali, Ahmidin11, Yili, Abulimiti11, Mirzaakhmedov, Sharafitdin1
Source: Journal of Computer-Aided Molecular Design; 7/5/2025, Vol. 39 Issue 1, p1-15, 15p
Database: Applied Science & Technology Source
Full text is not displayed to guests.
Description
ISSN:0920654X
DOI:10.1007/s10822-025-00623-2